<p>德意志銀行（Deutsche Bank Aktiengesellschaft）的股票分析師在週二向投資者發佈的報告中，將 Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）的評級從 “持有” 上調至 “買入”。該券商目前對該健康服務提供商的股票設定了 11.00 美元的目標價。德意志銀行的目標價意味着該股票有 107.35% 的潛在上漲空間，較其前一交易日收盤價而言。</p>
<p>獲取 <strong>Teladoc Health</strong> 的提醒：</p>
<ul>
<li>2 只可能受益於特朗普新任 FDA 官員的遠程醫療股票</li>
</ul>
<p>其他幾位股票分析師也最近對該股票發表了評論。Oppenheimer 將 Teladoc Health 的目標價從 12.00 美元下調至 7.00 美元，並在 3 月 3 日的報告中給予該股票 “跑贏大盤” 的評級。Canaccord Genuity Group 將 Teladoc Health 的目標價從 12.00 美元下調至 10.00 美元，並在 2 月 26 日的報告中給予該股票 “買入” 評級。富國銀行（Wells Fargo &amp; Company）在 2 月 26 日的研究報告中將 Teladoc Health 的目標價從 8.00 美元下調至 6.00 美元，並給予該股票 “持平” 的評級。巴克萊（Barclays）在 12 月 9 日的研究報告中開始覆蓋 Teladoc Health 的股票，給予 “持平” 評級和 8.50 美元的目標價。最後，花旗集團（Citigroup）在 3 月 3 日的研究報告中將 Teladoc Health 的目標價從 9.00 美元下調至 6.00 美元，並給予該公司的 “中性” 評級。六位研究分析師對該股票給予了 “買入” 評級，十三位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “持有”，共識目標價為 7.76 美元。</p>
<p><strong>查看我們關於 Teladoc Health 的最新報告</strong></p>
<h2>Teladoc Health 價格表現</h2>
<ul>
<li>2 只曾經的疫情明星股票瞄準 2025 年的大反轉</li>
</ul>
<p>週二，紐約證券交易所 TDOC 的開盤價為 5.31 美元。該公司的 50 日移動平均價格為 5.75 美元，200 日移動平均價格為 7.11 美元。該公司的速動比率為 2.67，流動比率為 2.77，債務與股本比率為 0.72。該股票的市值為 9.4641 億美元，市盈率為-4.65，貝塔值為 2.13。Teladoc Health 的 12 個月低點為 4.40 美元，12 個月高點為 9.77 美元。</p>
<p>Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）最近在 2 月 25 日發佈了季度財報。該健康服務提供商報告的每股收益（EPS）為-0.14 美元，超出分析師的共識預期（-0.19 美元）0.05 美元。Teladoc Health 的淨利潤率為-7.92%，股本回報率為-9.13%。該公司在本季度的收入為 6.4227 億美元，超過了共識預期的 6.3533 億美元。在去年同期，該公司的每股收益為-0.28 美元。該公司的季度收入同比增長 0.3%。Teladoc Health 已將其 2026 年第一季度的指導目標設定為-0.450 至-0.350 美元的每股收益，並將其 2026 財年的指導目標設定為-1.100 至-0.700 美元的每股收益。作為一個整體，股票分析師預測 Teladoc Health 在當前財年的每股收益為-1.16 美元。</p>
<h2>Teladoc Health 的內部活動</h2>
<ul>
<li>新任首席執行官能否復興這隻掙扎的遠程醫療股票？</li>
</ul>
<p>在其他 Teladoc Health 的新聞中，首席執行官 Charles Divita III 在 12 月 11 日的交易中出售了 17,138 股該股票。股份以平均價格 7.63 美元出售，總價值為 130,762.94 美元。出售後，首席執行官直接持有該公司 201,036 股股份，價值 1,533,904.68 美元。這代表其持股比例下降了 7.86%。該交易已在向 SEC 提交的文件中披露，文件可通過此鏈接獲取。公司內部人士持有該公司 0.58% 的股份。</p>
<h2>Teladoc Health 的機構交易</h2>
<p>一些對沖基金最近對該公司的持倉進行了調整。先鋒集團（Vanguard Group Inc.）在第三季度將其在 Teladoc Health 的持倉提高了 4.2%。先鋒集團目前持有該健康服務提供商 21,910,950 股股票，價值 169,372,000 美元，此前在上個季度增持了 891,732 股。Dimensional Fund Advisors LP 在第四季度將其在 Teladoc Health 的持倉提高了 8.8%。Dimensional Fund Advisors LP 目前持有該健康服務提供商 7,494,255 股股票，價值 52,459,000 美元，此前在上個季度增持了 605,061 股。Geode Capital Management LLC 在第四季度將其在 Teladoc Health 的持倉提高了 0.4%。Geode Capital Management LLC 目前持有該健康服務提供商 4,188,313 股股票，價值 29,324,000 美元，此前在上個季度增持了 18,394 股。Jupiter Asset Management Ltd.在第四季度將其在 Teladoc Health 的持倉提高了 293.9%。Jupiter Asset Management Ltd.目前持有該健康服務提供商 3,860,076 股股票，價值 27,021,000 美元，此前在該期間增持了 2,880,008 股。最後，Nuveen LLC 在第四季度將其在 Teladoc Health 的持倉提高了 38.7%。Nuveen LLC 目前持有該健康服務提供商 2,659,662 股股票，價值 18,618,000 美元，此前在上個季度增持了 742,240 股。76.82% 的股票由機構投資者和對沖基金持有。</p>
<h2>Teladoc Health 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Teladoc Health, Inc 是一家領先的全球虛擬醫療服務提供商，通過電話、視頻和移動應用平台提供按需醫療諮詢。該公司將患者與持牌醫生和專家連接，處理非緊急醫療問題、心理健康支持、皮膚病學和慢性病管理。通過利用數字技術和數據分析，Teladoc 旨在提高可及性，降低醫療成本，並通過個性化護理計劃和遠程監測改善患者的治療效果。</p>
<p>Teladoc 的服務組合包括普通醫療訪問、心理健康會話、複雜病例的專家醫療服務，以及旨在支持慢性病管理（如糖尿病、高血壓和心臟病）的健康計劃。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們認為比 Teladoc Health 更好的股票</li>
<li>在 2026 年 5 月 15 日之前購買這隻黃金股票</li>
<li>閲讀此文，否則將永遠後悔</li>
<li>摩根大通正在押注這枚幣</li>
<li>中央銀行剛剛做了一件自 1967 年以來未曾做過的事情</li>
<li>我的愛潑斯坦故事</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Teladoc Health 嗎？</h2>
<p>在考慮 Teladoc Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Teladoc Health 並不在名單上。</p>
<p>雖然 Teladoc Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HEAL

TDOC

遠程醫療和數字健康 ETF - GlobalX

FDHT

<p>德意志銀行股份公司將 Teladoc Health（紐約證券交易所代碼：TDOC）的評級從 “持有” 上調至 “買入”，設定目標價為 11.00 美元，意味着潛在上漲空間為 107.35%。其他分析師的看法各異，Oppenheimer 將目標價下調至 7.00 美元，Canaccord Genuity 則下調至 10.00 美元。目前，Teladoc 的共識評級為 “持有”，目標價為 7.76 美元。該股票開盤價為 5.31 美元，市值為 9.4641 億美元，最近一個季度的每股收益為（0.14 美元），超出預期。首席執行官 Charles Divita III 出售了部分股份，減少了其持股比例 7.86%</p>

<p>Teladoc Health (NYSE:TDOC - Get Free Report) was upgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a note issued to investors on Tuesday, Marketbeat.com reports. The brokerage presently has a $11.00 target price on the health services provider's stock. Deutsche Bank Aktiengesellschaft's price target points to a potential upside of 107.35% from the stock's previous close.</p>
<div class="lb-trans"><p>德意志銀行（Deutsche Bank Aktiengesellschaft）的股票分析師在週二向投資者發佈的報告中，將 Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）的評級從 “持有” 上調至 “買入”。該券商目前對該健康服務提供商的股票設定了 11.00 美元的目標價。德意志銀行的目標價意味着該股票有 107.35% 的潛在上漲空間，較其前一交易日收盤價而言。</p>
</div><p>Get <strong>Teladoc Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Teladoc Health</strong> 的提醒：</p>
</div><ul>
<li>2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只可能受益於特朗普新任 FDA 官員的遠程醫療股票</li>
</ul>
</div><p>Several other equities analysts also recently commented on the stock. Oppenheimer lowered their target price on shares of Teladoc Health from $12.00 to $7.00 and set an &#34;outperform&#34; rating on the stock in a report on Tuesday, March 3rd. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $12.00 to $10.00 and set a &#34;buy&#34; rating on the stock in a report on Thursday, February 26th. Wells Fargo &amp; Company decreased their price target on Teladoc Health from $8.00 to $6.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Thursday, February 26th. Barclays assumed coverage on shares of Teladoc Health in a research report on Tuesday, December 9th. They set an &#34;equal weight&#34; rating and a $8.50 price target for the company. Finally, Citigroup dropped their price objective on shares of Teladoc Health from $9.00 to $6.00 and set a &#34;neutral&#34; rating for the company in a research note on Tuesday, March 3rd. Six research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $7.76.</p>
<div class="lb-trans"><p>其他幾位股票分析師也最近對該股票發表了評論。Oppenheimer 將 Teladoc Health 的目標價從 12.00 美元下調至 7.00 美元，並在 3 月 3 日的報告中給予該股票 “跑贏大盤” 的評級。Canaccord Genuity Group 將 Teladoc Health 的目標價從 12.00 美元下調至 10.00 美元，並在 2 月 26 日的報告中給予該股票 “買入” 評級。富國銀行（Wells Fargo &amp; Company）在 2 月 26 日的研究報告中將 Teladoc Health 的目標價從 8.00 美元下調至 6.00 美元，並給予該股票 “持平” 的評級。巴克萊（Barclays）在 12 月 9 日的研究報告中開始覆蓋 Teladoc Health 的股票，給予 “持平” 評級和 8.50 美元的目標價。最後，花旗集團（Citigroup）在 3 月 3 日的研究報告中將 Teladoc Health 的目標價從 9.00 美元下調至 6.00 美元，並給予該公司的 “中性” 評級。六位研究分析師對該股票給予了 “買入” 評級，十三位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “持有”，共識目標價為 7.76 美元。</p>
</div><p><strong>Check Out Our Latest Report on Teladoc Health</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Teladoc Health 的最新報告</strong></p>
</div><h2>Teladoc Health Price Performance</h2>
<div class="lb-trans"><h2>Teladoc Health 價格表現</h2>
</div><ul>
<li>2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只曾經的疫情明星股票瞄準 2025 年的大反轉</li>
</ul>
</div><p>NYSE TDOC opened at $5.31 on Tuesday. The company has a 50 day moving average price of $5.75 and a two-hundred day moving average price of $7.11. The company has a quick ratio of 2.67, a current ratio of 2.77 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $946.41 million, a PE ratio of -4.65 and a beta of 2.13. Teladoc Health has a 12-month low of $4.40 and a 12-month high of $9.77.</p>
<div class="lb-trans"><p>週二，紐約證券交易所 TDOC 的開盤價為 5.31 美元。該公司的 50 日移動平均價格為 5.75 美元，200 日移動平均價格為 7.11 美元。該公司的速動比率為 2.67，流動比率為 2.77，債務與股本比率為 0.72。該股票的市值為 9.4641 億美元，市盈率為-4.65，貝塔值為 2.13。Teladoc Health 的 12 個月低點為 4.40 美元，12 個月高點為 9.77 美元。</p>
</div><p>Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The health services provider reported ($0.14) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.05. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The company had revenue of $642.27 million during the quarter, compared to the consensus estimate of $635.33 million. During the same period in the prior year, the business posted ($0.28) EPS. The company's quarterly revenue was up .3% on a year-over-year basis. Teladoc Health has set its Q1 2026 guidance at -0.450--0.350 EPS and its FY 2026 guidance at -1.100--0.700 EPS. As a group, equities analysts predict that Teladoc Health will post -1.16 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Teladoc Health（紐約證券交易所代碼：TDOC - 獲取免費報告）最近在 2 月 25 日發佈了季度財報。該健康服務提供商報告的每股收益（EPS）為-0.14 美元，超出分析師的共識預期（-0.19 美元）0.05 美元。Teladoc Health 的淨利潤率為-7.92%，股本回報率為-9.13%。該公司在本季度的收入為 6.4227 億美元，超過了共識預期的 6.3533 億美元。在去年同期，該公司的每股收益為-0.28 美元。該公司的季度收入同比增長 0.3%。Teladoc Health 已將其 2026 年第一季度的指導目標設定為-0.450 至-0.350 美元的每股收益，並將其 2026 財年的指導目標設定為-1.100 至-0.700 美元的每股收益。作為一個整體，股票分析師預測 Teladoc Health 在當前財年的每股收益為-1.16 美元。</p>
</div><h2>Insider Activity at Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的內部活動</h2>
</div><ul>
<li>Can the New CEO Revive This Struggling Telehealth Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>新任首席執行官能否復興這隻掙扎的遠程醫療股票？</li>
</ul>
</div><p>In other Teladoc Health news, CEO Charles Divita III sold 17,138 shares of the stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $7.63, for a total value of $130,762.94. Following the sale, the chief executive officer directly owned 201,036 shares in the company, valued at $1,533,904.68. This represents a 7.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.58% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Teladoc Health 的新聞中，首席執行官 Charles Divita III 在 12 月 11 日的交易中出售了 17,138 股該股票。股份以平均價格 7.63 美元出售，總價值為 130,762.94 美元。出售後，首席執行官直接持有該公司 201,036 股股份，價值 1,533,904.68 美元。這代表其持股比例下降了 7.86%。該交易已在向 SEC 提交的文件中披露，文件可通過此鏈接獲取。公司內部人士持有該公司 0.58% 的股份。</p>
</div><h2>Institutional Trading of Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的機構交易</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Teladoc Health by 4.2% during the third quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider's stock worth $169,372,000 after acquiring an additional 891,732 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Teladoc Health by 8.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 7,494,255 shares of the health services provider's stock worth $52,459,000 after purchasing an additional 605,061 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Teladoc Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 4,188,313 shares of the health services provider's stock valued at $29,324,000 after buying an additional 18,394 shares in the last quarter. Jupiter Asset Management Ltd. increased its holdings in shares of Teladoc Health by 293.9% in the 4th quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider's stock valued at $27,021,000 after acquiring an additional 2,880,008 shares during the period. Finally, Nuveen LLC boosted its holdings in Teladoc Health by 38.7% during the fourth quarter. Nuveen LLC now owns 2,659,662 shares of the health services provider's stock worth $18,618,000 after buying an additional 742,240 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些對沖基金最近對該公司的持倉進行了調整。先鋒集團（Vanguard Group Inc.）在第三季度將其在 Teladoc Health 的持倉提高了 4.2%。先鋒集團目前持有該健康服務提供商 21,910,950 股股票，價值 169,372,000 美元，此前在上個季度增持了 891,732 股。Dimensional Fund Advisors LP 在第四季度將其在 Teladoc Health 的持倉提高了 8.8%。Dimensional Fund Advisors LP 目前持有該健康服務提供商 7,494,255 股股票，價值 52,459,000 美元，此前在上個季度增持了 605,061 股。Geode Capital Management LLC 在第四季度將其在 Teladoc Health 的持倉提高了 0.4%。Geode Capital Management LLC 目前持有該健康服務提供商 4,188,313 股股票，價值 29,324,000 美元，此前在上個季度增持了 18,394 股。Jupiter Asset Management Ltd.在第四季度將其在 Teladoc Health 的持倉提高了 293.9%。Jupiter Asset Management Ltd.目前持有該健康服務提供商 3,860,076 股股票，價值 27,021,000 美元，此前在該期間增持了 2,880,008 股。最後，Nuveen LLC 在第四季度將其在 Teladoc Health 的持倉提高了 38.7%。Nuveen LLC 目前持有該健康服務提供商 2,659,662 股股票，價值 18,618,000 美元，此前在上個季度增持了 742,240 股。76.82% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Teladoc Health Company Profile</h2>
<div class="lb-trans"><h2>Teladoc Health 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.</p>
<div class="lb-trans"><p>Teladoc Health, Inc 是一家領先的全球虛擬醫療服務提供商，通過電話、視頻和移動應用平台提供按需醫療諮詢。該公司將患者與持牌醫生和專家連接，處理非緊急醫療問題、心理健康支持、皮膚病學和慢性病管理。通過利用數字技術和數據分析，Teladoc 旨在提高可及性，降低醫療成本，並通過個性化護理計劃和遠程監測改善患者的治療效果。</p>
</div><p>Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.</p>
<div class="lb-trans"><p>Teladoc 的服務組合包括普通醫療訪問、心理健康會話、複雜病例的專家醫療服務，以及旨在支持慢性病管理（如糖尿病、高血壓和心臟病）的健康計劃。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Teladoc Health</li>
<li>Buy this Gold Stock Before May 15th, 2026</li>
<li>Read this or regret it forever</li>
<li>J.P. Morgan is betting on this coin</li>
<li>Central banks just did something they haven’t done since 1967</li>
<li>My Epstein Story</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Teladoc Health 更好的股票</li>
<li>在 2026 年 5 月 15 日之前購買這隻黃金股票</li>
<li>閲讀此文，否則將永遠後悔</li>
<li>摩根大通正在押注這枚幣</li>
<li>中央銀行剛剛做了一件自 1967 年以來未曾做過的事情</li>
<li>我的愛潑斯坦故事</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=TDOC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Teladoc Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Teladoc Health 嗎？</h2>
</div><p>Before you consider Teladoc Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Teladoc Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Teladoc Health 並不在名單上。</p>
</div><p>While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Teladoc Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Teladoc Health（NYSE 代碼：TDOC）在德意志銀行股份公司獲得評級上調